insights_auto
Outlook: 22.2% bullish·16.7% bearish
Pumunta sa pagsusurichevron_right
A1RG34:BVMF
Argenx Se Bdr
R$165.44
0.00%
(0.00) 1D
Okt 9, 4:56:00 PM GMT-3 · BRL
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa A1RG34...
Buksan
R$165.44
Mataas
R$165.44
Mababa
R$165.44
Mkt. cap
50.06B
Avg. na dami
59.00
Dami
8.00
Mataas nang 52-wk
R$213.15
Mababa nang 52-wk
R$143.22
Mga natitirang share
62.89M
Bilang ng mga empleyado
2K
Buksan
R$165.44
Mataas
R$165.44
Mababa
R$165.44
Mkt. cap
50.06B
Avg. na dami
59.00
Dami
8.00
Mataas nang 52-wk
R$213.15
Mababa nang 52-wk
R$143.22
Mga natitirang share
62.89M
Bilang ng mga empleyado
2K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Simply Wall Street
·
1 araw ang nakalipas
Could A Halted Sjögren Trial Alter The Investment Case For argenx Stock?
Yahoo Finance
·
1 araw ang nakalipas
argenx (ENXTBR:ARGX) Stock May Be Fully Priced After Its 185% Run
AD HOC NEWS
·
1 araw ang nakalipas
Argenx stock sits at EUR 736.30 after a week of mixed trial news
Investing.com
·
2 araw ang nakalipas
H.C. Wainwright reiterates argenx stock buy rating on celiac drug data
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
Tungkol sa Argenx Se Bdr